In January 2026, the American Heart and American Stroke Association (AHA/ASA) issued new care guidelines for acute ischemic stroke (AIS) patients.
The entities’ “2026 Guideline for the Early Management of Patients With AIS” replaces both the 2018 guidelines and the 2019 update to reflect recent advances in evidence.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Guidance from the entities tends to inform stroke care guidelines on a global basis. The 2026 guidelines outline several recommended care shifts, including the broader use of advanced imaging to guide treatment decisions, expanded eligibility for reperfusion therapies, and a system-wide push to reduce delays across the entire stroke pathway.
In this episode, Medical Device Network spoke with George Harston, chief medical and innovation officer at Brainomix, to learn more about what the updated guidelines mean and how they can be implemented successfully.
Listen to the full episode below:
